Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Cheng-Dong Qin"'
Autor:
Man-Qing Cao, A-Bin You, Xiao-Dong Zhu, Wei Zhang, Yuan-Yuan Zhang, Shi-Zhe Zhang, Ke-wei Zhang, Hao Cai, Wen-Kai Shi, Xiao-Long Li, Kang-Shuai Li, Dong-Mei Gao, De-Ning Ma, Bo-Gen Ye, Cheng-Hao Wang, Cheng-Dong Qin, Hui-Chuan Sun, Ti Zhang, Zhao-You Tang
Publikováno v:
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-12 (2018)
Abstract Background High frequency of recurrence is the major cause of the poor outcomes for patients with hepatocellular carcinoma (HCC). microRNA (miR)-182-5p emerged as a high-priority miRNA in HCC and was found to be related to HCC metastasis. Wh
Externí odkaz:
https://doaj.org/article/eb5ff33fdd4f47ae85573d269ef5adff
Autor:
De-Ning Ma, Zong-Tao Chai, Xiao-Dong Zhu, Ning Zhang, Di-Hua Zhan, Bo-Gen Ye, Cheng-Hao Wang, Cheng-Dong Qin, Yi-Ming Zhao, Wei-Ping Zhu, Man-Qing Cao, Dong-Mei Gao, Hui-Chuan Sun, Zhao-You Tang
Publikováno v:
Journal of Hematology & Oncology, Vol 9, Iss 1, Pp 1-10 (2016)
Abstract Background Our previous study reported that microRNA-26a (miR-26a) inhibited tumor progression by inhibiting tumor angiogenesis and intratumoral macrophage infiltration in hepatocellular carcinoma (HCC). The direct roles of miR-26a on tumor
Externí odkaz:
https://doaj.org/article/0f5a428ecebc43d89ada3e41b63c0d1c
Autor:
Man-Qing Cao, A-Bin You, Xiao-Dong Zhu, Wei Zhang, Yuan-Yuan Zhang, Shi-Zhe Zhang, Kei-wei Zhang, Hao Cai, Wen-Kai Shi, Xiao-Long Li, Kang-Shuai Li, Dong-Mei Gao, De-Ning Ma, Bo-Gen Ye, Cheng-Hao Wang, Cheng-Dong Qin, Hui-Chan Sun, Ti Zhang, Zhao-You Tang
Publikováno v:
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-1 (2018)
The original article [1] contains an error in Fig. 5a whereby the Western blot bands representing CyclinD1 have mistakenly been duplicated over the Western blot bands intended to represent SGK.
Externí odkaz:
https://doaj.org/article/7a91d64a4bca4105bfd8c2a070c8fa05
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Purpose Radiofrequency ablation (RFA) therapy has proven to be effective and feasible for early-stage hepatocellular carcinoma (HCC); however, rapid progression of residual tumor cells after RFA has been confirmed, but the molecular mechanisms of thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba75fcfe3d30d9fe5e0bde2d943d18da
https://doi.org/10.1007/s00432-019-02852-z
https://doi.org/10.1007/s00432-019-02852-z
Publikováno v:
OncoTargets and therapy
Dong-Min Shi,* Xin-Yu Bian,* Cheng-Dong Qin,* Wei-Zhong Wu Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, People’s Republic of China *These author
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c54a5a1f27a19e7395768ed575cbce5
https://doi.org/10.2147/ott.s152611
https://doi.org/10.2147/ott.s152611
Publikováno v:
Optics and Precision Engineering. 25:891-899
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fc00b564a28b661af5f33723dd56d94
https://doi.org/10.3788/ope.20172504.0891
https://doi.org/10.3788/ope.20172504.0891
Autor:
Zhao-You Tang, Cheng-Hao Wang, Dong-Mei Gao, Yuan-Yuan Zhang, De-Ning Ma, Bo-Gen Ye, Hao Cai, Zong-Tao Chai, Hui-Chuan Sun, Cheng-Dong Qin, Jian-Yang Ao, Xiao-Dong Zhu
Publikováno v:
Oncotarget
Tumor-associated endothelial cells (TEC) directly facilitate tumor progression, but little is known about the mechanisms. We investigated the function of CD109 in TEC and its clinical significance in hepatocellular carcinoma (HCC). The correlation be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e759c7376fa9ad27ffb21747f2ace205
http://europepmc.org/articles/PMC5045399
http://europepmc.org/articles/PMC5045399
Autor:
Wei Zhang, Cheng-Dong Qin, Zhao-You Tang, Ti Zhang, Man-Qing Cao, De-Ning Ma, Kang-Shuai Li, Dong-Mei Gao, Cheng-Hao Wang, Yuan-Yuan Zhang, A-Bin You, Wen-Kai Shi, Xiao-Dong Zhu, Bo-Gen Ye, Shi-Zhe Zhang, Xiao-Long Li, Hui-Chuan Sun, Ke‑Wei Zhang, Hao Cai
Publikováno v:
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-12 (2018)
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-12 (2018)
Background High frequency of recurrence is the major cause of the poor outcomes for patients with hepatocellular carcinoma (HCC). microRNA (miR)-182-5p emerged as a high-priority miRNA in HCC and was found to be related to HCC metastasis. Whether the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9627599eb6863f8875c24451c8ab5107
http://europepmc.org/articles/PMC5782375
http://europepmc.org/articles/PMC5782375
Autor:
Shi-Zhe Zhang, Qing-An Jia, Cheng-Dong Qin, Zong-Tao Chai, Zhao-You Tang, Cheng-Hao Wang, Ning Zhang, Hui-Chuan Sun, Xiao-Dong Zhu, De-Ning Ma, Zhenggang Ren
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 9, Iss 5, Pp 1-18 (2018)
Cell Death and Disease, Vol 9, Iss 5, Pp 1-18 (2018)
Rnd1, a member of Rho GTPases, was found to be downregulated in human malignancies and downregulation of Rnd1 promotes tumor invasion via various mechanisms. However, the role of Rnd1 in hepatocellular carcinoma (HCC) progression remains unclear. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::532fa34d832f2af3d6feb414a0eab972
https://pubmed.ncbi.nlm.nih.gov/29706627
https://pubmed.ncbi.nlm.nih.gov/29706627
Autor:
Cheng-Hao, Wang, Xiao-Dong, Zhu, De-Ning, Ma, Hui-Chuan, Sun, Dong-Mei, Gao, Ning, Zhang, Cheng-Dong, Qin, Yuan-Yuan, Zhang, Bo-Gen, Ye, Hao, Cai, Wen-Kai, Shi, Man-Qin, Cao, Zhao-You, Tang
Publikováno v:
American journal of cancer research. 7(5)
Flotillin-2 (Flot2) is a highly conserved and ubiquitously expressed protein that resides on the cytoplasmic side of the cell membrane within specific cholesterol rich microdomains. Some studies have reported that overexpression of Flot2 is related t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::23d5dff7ab1c88cd20c43c494a30624f
https://pubmed.ncbi.nlm.nih.gov/28560058
https://pubmed.ncbi.nlm.nih.gov/28560058